In the March issue of the medical journal Academic Emergency Medicine, researchers from around the world found a disturbing correlation between the incidence of Xarelto-related bleeding in patients who are already at a higher risk for pulmonary embolism (PE). The study, sponsored by the manufacturers of Xarelto, Bayer HealthCare and Janssen, included about 5,000 patients at risk of pulmonary embolism. What they found was that while Xarelto can be relatively safe for most patients who already have a low to moderate risk of blood clots traveling to the lungs, patients who were at a high risk for pulmonary embolism will face a higher chance of experiencing Xarelto-related bleeding. Researchers found that the incidence in those already facing a higher risk of PE were twice as likely as other patients to experience a bleeding injury while taking Xarelto.
In other words, it would be advisable for patients with a higher risk of PE to think twice about taking Xarelto. While many doctors prescribe the blockbuster drug because it requires less monitoring on their behalf, they should be alert to this finding and advise their patients accordingly. The drug has recently come under scrutiny for its negative side effects, specifically the risk of uncontrollable bleeding, which could in turn has caused several cases of severe injury and even death. Unfortunately, this particular blood thinner currently does not have an approved antidote to stop uncontrollable bleeding, leaving doctors and patients alike with few solutions or treatments to turn to.
Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.